Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)
CUSIP: 45782T105
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 27,969,231
- Total 13F shares
- 1,710,752
- Share change
- +404,937
- Total reported value
- $30,053,028
- Put/Call ratio
- 92%
- Price per share
- $17.57
- Number of holders
- 39
- Value change
- +$8,038,213
- Number of buys
- 23
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45782T105:
Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
313,220
|
$3,721,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.84%
|
233,576
|
$2,775,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.79%
|
219,730
|
$2,611,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.38%
|
106,048
|
$1,260,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.23%
|
65,544
|
$779,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
60,837
|
$722,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.17%
|
47,076
|
$536,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
41,988
|
$499,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
33,072
|
$393,000 | — | 31 Mar 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
32,070
|
$381,000 | — | 31 Mar 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.08%
|
22,055
|
$262,000 | — | 31 Mar 2021 | |
| Financial Advocates Investment Management |
13F
|
Company |
0.07%
|
19,667
|
$234,000 | — | 31 Mar 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.06%
|
17,073
|
$203,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
13,949
|
$166,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.05%
|
13,663
|
$162,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.05%
|
13,365
|
$159,000 | — | 31 Mar 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
12,221
|
$145,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
11,052
|
$131,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
7,982
|
$94,000 | — | 31 Mar 2021 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.02%
|
6,200
|
$73,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,309
|
$39,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,093
|
$37,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
1,908
|
$23,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
1,700
|
$20,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
1,667
|
$20,000 | — | 31 Mar 2021 | |
| Covington Capital Management |
13F
|
Company |
0%
|
1,000
|
$12,000 | — | 31 Mar 2021 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
700
|
$12,000 | — | 31 Mar 2021 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
814
|
$10,000 | — | 31 Mar 2021 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
500
|
$5,940 | — | 31 Mar 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
400
|
$4,752 | — | 31 Mar 2021 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
184
|
$2,000 | — | 31 Mar 2021 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
52
|
$1,000 | — | 31 Mar 2021 |
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2021
As of 30 Jun 2021,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,710,752 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., EAM Investors, LLC, Ikarian Capital, LLC, EAM Global Investors LLC, DEUTSCHE BANK AG\, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, ROYAL BANK OF CANADA, and Janney Montgomery Scott LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
32
Q2 2021 holders
39
Holder diff
7
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.